{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T17:51:10Z","timestamp":1720201870688},"reference-count":61,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JEP"],"DOI":"10.2147\/jep.s332715","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T18:00:31Z","timestamp":1644343231000},"page":"43-57","source":"Crossref","is-referenced-by-count":2,"title":["Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2\/D3 Selective Receptor Antagonist for the Management of Gastroparesis"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Laura","family":"Kreckler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Osinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roger","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,2]]},"reference":[{"key":"ref1","first-page":"1069","volume":"84","author":"Koch","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s00221-014-4007-9","volume":"232","author":"Koch","year":"2014","journal-title":"Exp Brain Res"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/s41572-018-0038-z","volume":"4","author":"Camilleri","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1080\/00365521.2018.1558280","volume":"54","author":"Bekkelund","year":"2019","journal-title":"Scand J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1016\/j.cgh.2019.04.039","volume":"17","author":"Gharibans","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2004.09.055","volume":"127","author":"Parkman","year":"2004","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"340","DOI":"10.14740\/gr1060w","volume":"11","author":"Nassar","year":"2018","journal-title":"Gastroenterol Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/1751-2980.12344","volume":"17","author":"Bharadwaj","year":"2016","journal-title":"J Dig Dis"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1136\/gutjnl-2019-318712","volume":"68","author":"Grover","year":"2019","journal-title":"Gut"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1053\/j.gastro.2008.12.047","volume":"136","author":"Jung","year":"2009","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1097\/MCG.0000000000001231","volume":"54","author":"Syed","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.giec.2018.08.010","volume":"29","author":"Moshiree","year":"2019","journal-title":"Gastrointestinal Endoscopy Clin"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/ajg.2013.118","volume":"108","author":"Janssen","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1586\/eem.10.41","volume":"5","author":"Lee","year":"2010","journal-title":"Expert Rev Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s007020050222","volume":"106","author":"Darmani","year":"1999","journal-title":"J Neural Transm"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10620-008-0335-6","volume":"54","author":"Kashyap","year":"2009","journal-title":"Dig Dis Sci"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2036.2004.01867.x","volume":"19","author":"Tonini","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.14309\/00000434-200509001-00094","volume":"100","author":"Kashyap","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2147\/CEG.S50236","volume":"6","author":"Enweluzo","year":"2013","journal-title":"Clin Exp Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/nmo.12519","volume":"27","author":"Homko","year":"2015","journal-title":"Neurogastroenterol Motility"},{"key":"ref21","volume-title":"Treatment of Gastroparesis"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2036.2009.04189.x","volume":"31","author":"Rao","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5348\/ijcri-2012-05-116-RA-1","volume":"3","author":"Rumore","year":"2012","journal-title":"Int J Case Rep Images"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.gtc.2014.11.008","volume":"44","author":"Acosta","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e13617","DOI":"10.1111\/nmo.13617","volume":"31","author":"Al\u2010Saffar","year":"2019","journal-title":"Neurogastroenterol Motility"},{"key":"ref26","unstructured":"European Medicines Agency (EMA). European Medicines Agency recommends changes to the use of metoclopramide; 2013. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Metoclopramide_31\/WC500146610.pdf. Accessed January 2020."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/FJC.0b013e31827e2573","volume":"61","author":"Michaud","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref28","unstructured":"European Medicines Agency (EMA). Domperidone summary of product characteristics; 2017. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/556\/smpc#POSOLOGY. Accessed January 2020."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2174\/157488610791698334","volume":"5","author":"Rossi","year":"2010","journal-title":"Curr Drug Saf"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s40261-015-0360-0","volume":"36","author":"Leelakanok","year":"2016","journal-title":"Clin Drug Investig"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/00365521.2017.1401117","volume":"53","author":"Hellstr\u00f6m","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1365-2125.2011.04093.x","volume":"73","author":"Boyce","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/cpdd.126","volume":"4","author":"Biewenga","year":"2015","journal-title":"Clin Pharmacol Drug Develop"},{"key":"ref34","unstructured":"Jolas T. In Vitro Pharmacology Study of ATC-1906M and ATC-9984. Eurofins Cerep: Cerep study number 100009687. 2013"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"S638","DOI":"10.1016\/S0016-5085(20)32292-7","volume":"158","author":"Whiting","year":"2020","journal-title":"Gastroenterology"},{"key":"ref36","unstructured":"Eurofins Cerep: Cerep Study Number 100018069."},{"key":"ref37","unstructured":"Eurofins Cerep: Cerep Study Number 100019379."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1002\/cpdd.906","volume":"10","author":"Whiting","year":"2021","journal-title":"Clin Pharmacol Drug Develop"},{"key":"ref39","unstructured":"Williams S. Covance Laboratories Inc.. Covance Study Number 8294200. Escalating Repeat-Dose Range-Finding Toxicity Study with ATC-1906 (Maleate Salt) in Rats. 2014."},{"key":"ref40","unstructured":"Covance Laboratories Inc.. Covance Study Number 8294202. Escalating-Dose Range-Finding Study (Phase I) and 7-Day Repeat-Dose Toxicity and Toxicokinetics (Phase II) Oral Capsule Study with ATC-1906 (Maleate Salt) in Dogs."},{"key":"ref41","unstructured":"Williams S. Covance Laboratories Inc.. Covance Study Number 8294203. A 4-Week Oral Capsule Toxicity and Toxicokinetic Study of ATC-1906 (Maleate Salt) in Dogs with a 2-Week Recovery Phase. 2014."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1542-474X.2006.00120.x","volume":"11","author":"King","year":"2006","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"ref43","volume-title":"Statistical Principles in Experimental Design","year":"1991a"},{"key":"ref44","volume-title":"Statistical Principles in Experimental Design","year":"1991b"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","volume":"50","author":"Dunnett","year":"1955","journal-title":"J Am Stat Assoc"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"482","DOI":"10.2307\/2528490","volume":"20","author":"Dunnett","year":"1964","journal-title":"Biometrics"},{"key":"ref47","volume-title":"Multiple Comparisons: Theory and Methods","year":"1996"},{"key":"ref48","unstructured":"Dinkel V, Harris D. Covance Laboratories Inc.. Covance Study Number 8320963. Concentrations of Prolactin in Serum and of ATC-1906 in Plasma and CSF Levels After Multiple Oral Doses of ATC-1906M to Rats. 2015."},{"key":"ref49","unstructured":"Dinkel V, Harris D. Covance Laboratories Inc.. Covance Study Number 8320964. Concentrations of Prolactin in Serum and of ATC-1906 in Plasma and CSF Levels After Multiple Oral Doses of ATC-1906M to Dogs. 2015."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.1021\/jm501535r","volume":"58","author":"Rankovic","year":"2015","journal-title":"J Med Chem"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fasebj.2020.34.s1.09414","volume":"34","author":"Jasper","year":"2020","journal-title":"J Fed Am Soc Exp Biol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1002\/jps.2600760902","volume":"76","author":"Hansch","year":"1987","journal-title":"J Pharm Sci"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0099-5428(08)60560-2","volume":"16","author":"Pitr\u00e8","year":"1987","journal-title":"Anal Profiles Drug Substances"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2006.12.004","volume":"56","author":"Jolliet","year":"2007","journal-title":"Pharmacol Res"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.2967\/jnumed.118.219972","volume":"60","author":"Tournier","year":"2019","journal-title":"J Nucl Med"},{"key":"ref56","unstructured":"Burton C, Krueger M. Covance Laboratories Inc.. Covance Study Number 8328073. Determination of Prolactin Levels After a Single Oral Dose of ATC-1906M or Domperidone to Rats. 2015."},{"key":"ref57","unstructured":"Whiting R. Covance Laboratories Inc.. Covance Study Number 8335390. A Phase 1, Adaptive-Design, First-In-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Study of Safety, Tolerability, Pharmacokinetics, Food Effect, and Pharmacodynamics of ATC-1906M Capsules in Healthy Volunteers. 2016."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/apt.16451","volume":"54","author":"Kuo","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"ref59","unstructured":"ChanTest: Study number 131015.BMX. Effect of TAK-906 on Cloned hERG Potassium Channels Expressed in Human Embryonic Kidney Cells."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000083234","volume":"74","author":"Claassen","year":"2005","journal-title":"Pharmacology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1517\/14740338.2014.851193","volume":"13","author":"Doggrell","year":"2014","journal-title":"Expert Opin Drug Saf"}],"container-title":["Journal of Experimental Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78174","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=78174","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T18:00:41Z","timestamp":1644343241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/non-clinical-safety-pharmacology-evaluations-of-trazpiroben-tak-906-a--peer-reviewed-fulltext-article-JEP"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":61,"URL":"https:\/\/doi.org\/10.2147\/jep.s332715","relation":{},"ISSN":["1179-1454"],"issn-type":[{"value":"1179-1454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2]]}}}